Morepen Laboratories Limited — Updates, 04-08-2026: General Updates
04-08-2026 | 02:36 pm
04-08-2026 | 02:36 pm
Morepen Labs reported robust Q1 financial results: Consolidated revenue surged to ₹570.13 Cr and profit to ₹56.35 Cr. The board extended the medical devices business hive-off timeline and proposed re-appointing Sushil Suri as CMD for three years.
No comments yet. Be the first to comment!
